Riskpilot← Back to searchSign inGet full accessCMM Innovation AB
ABActiveOrg 5591438113171 76 StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
-584% vs 2023
Equity ratio
96.9%
Financial strength
Net profit 2024
SEK -201K
-658% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -208K | -584% |
| Net profit | SEK -201K | -658% |
| Total assets | SEK 549K | -28% |
| Equity | SEK 532K | -27% |
| Employees | 0 | — |
Legal name
CMM Innovation AB
Org number
5591438113
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 januari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Aktiebolaget ska utveckla medicinska innovationer som härör från Stiftelsen för Molekylär Medicin samt utveckla infrastruktur som stödjer forskning och därmed förenlig verksamhet.
Address
171 76 Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 459 | 459 | 511 | 318 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 133 | 68 | 69 | 43 | −208 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 133 | 68 | 69 | 43 | −208 |
| Net financials | — | — | — | 3 | 7 |
| Profit before tax | 133 | 68 | 69 | 45 | −201 |
| Tax | −24 | −14 | −14 | −9 | −0 |
| Net profit | 109 | 54 | 55 | 36 | −201 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 685 | 725 | 793 | 765 | 549 |
| Equity | 588 | 642 | 697 | 733 | 532 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 97 | 83 | 96 | 32 | 17 |
| Total debt | 97 | 83 | 96 | 32 | 17 |
EBITDA margin
-20800000.0%
This company
15.8%
Market median
-131645670% vs market
20202024
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
-37.8%
This company
18.4%
Market median
-305% vs market
20202024
Net profit margin
-20100000.0%
This company
8.1%
Market median
-248148248% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CMM Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Michael Sundström | Board of Directors | 0 companies |
| Lars Göran Yngve Klareskog | Board of Directors | 0 companies |
| Liselotte Ingegerd Jansson | Chairman | 0 companies |